Use of Thoracoscopic Intraoperative Lung Ultrasound to Identify Pulmonary Metastases in Patients Submitted to Pulmonary Metastasectomy With Radical Intent. (VATS-US1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03864874 |
|
Recruitment Status :
Recruiting
First Posted : March 6, 2019
Last Update Posted : July 8, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Experience drawn from many scientific articles showed that many patients who develop a limited pattern of pulmonary metastases after treatment of a primary tumor may benefit from surgical resection of the lung deposits. Pulmonary metastasectomy with curative intent is widely performed with the aim of prolonging life and, in some cases, being curative. Usually the surgical strategy is defined based on analysis of radiological investigations, performed during a follow-up program after resection of a tumor. However, many studies showed that the actual sensitivity of this examinations, namely computed tomography (CT) and positron-emission tomography (PET) is far from being 100% and finding further unexpected nodules at operation with lung manual palpation is not uncommon. Many surgeons perform pulmonary metastasectomy with a minimally invasive approach, in view of a less morbid and more cosmetic approach, but lung palpation is considerably hampered and surgical radicality might be impaired. With this study the investigators want to assess the ability of lung ultrasonography performed via a key-hole access (thoracoscopy, VATS) in detecting lung nodules compared with the standard practice represented by open thoracotomy, that is a wider incision that allows manual exploration of the organ. Therefore, every patient enrolled will undergo a double phase surgical approach: a first phase by thoracoscopy where a thorough lung ultrasonography will be performed and number and position of lung nodules will be annotated, and a second phase by open thoracotomy where lung is palpated and suspicious nodules will be removed. The incisions used for the first phase will be extended for the second, rendering any other procedure for the execution of lung ultrasonography unnecessary.
Should this study demonstrate a non-inferiority of lung ultrasonography in detecting lung nodules compared with manual palpation of the lung, patients should be offered a less invasive approach for treatment of their condition with no concerns regarding a potential lower therapeutic effect.
| Condition or disease | Intervention/treatment |
|---|---|
| Pulmonary Metastases | Diagnostic Test: Intraoperative intracavitary lung ultrasonography |
Show detailed description
| Study Type : | Observational |
| Estimated Enrollment : | 89 participants |
| Observational Model: | Other |
| Time Perspective: | Cross-Sectional |
| Official Title: | Thoracoscopic Ultrasonography Versus Manual Lung Palpation by Thoracotomy for the Identification of Lung Nodules During Pulmonary Metastasectomy. A Prospective Blinded Cross-over Trial. |
| Actual Study Start Date : | January 1, 2019 |
| Estimated Primary Completion Date : | December 31, 2021 |
| Estimated Study Completion Date : | January 15, 2022 |
- Diagnostic Test: Intraoperative intracavitary lung ultrasonography
Ultrasonography on the deflated lung for detection of lung nodules
- Number of nodules/lesions identified: surgery [ Time Frame: Intraoperative ]Number of nodules identified at VATS-US and lung palpation/ number of lesions identified at lung palpation
- Number of nodules/lesions identified: histology [ Time Frame: Up to 2 weeks ]Number of nodules identified at VATS-US and lung palpation/ number of lesions confirmed to be pulmonary metastases
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patient candidate to pulmonary metastasectomy with curative intent by mean of both major anatomical or limited resection;
- Age > 18 years.
Exclusion Criteria:
- Patients with widespread metastatic disease where surgical resection is performed only for diagnostic purposes;
- History of previous intrapleural talc injection;
- Any anatomical or pathological condition (eg. diffuse adhesions, severe emphysema) that may interfere with execution of ultrasonographic investigation;
- Incomplete lung exclusion during surgical procedure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03864874
| Contact: francesco londero, MD | +390432554069 | francesco.londero@asuiud.sanita.fvg.it |
| Italy | |
| Thoracic Surgery Unit, Cardiothoracic Dept., ASUI S Maria della Misericordia | Recruiting |
| Udine, Ud, Italy, 33100 | |
| Contact: francesco londero 00390432554069 francesco.londero@asuiud.sanita.fvg.it | |
| Principal Investigator: | Francesco Londero, MD | Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine | |
| Study Director: | Angelo Morelli, MD | Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine | |
| Study Chair: | Sandro Gelsomino, MD, PhD, FESC | Cardiothoracic Department Maastricht University Hospital, Maastricht, The Netherlands | |
| Study Chair: | Luigi Castriotta, MD | Clinical Epidemiology Department, ASUI S Maria della Misericordia, Udine | |
| Study Chair: | William Grossi, MD | Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine | |
| Study Chair: | Gianluca Masullo, MD | Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Francesco Londero, Principal Investigator, Azienda Sanitaria-Universitaria Integrata di Udine |
| ClinicalTrials.gov Identifier: | NCT03864874 |
| Other Study ID Numbers: |
30948 |
| First Posted: | March 6, 2019 Key Record Dates |
| Last Update Posted: | July 8, 2020 |
| Last Verified: | July 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pulmonary metastases Intraoperative ultrasonography Thoracoscopy Lung |
|
Neoplasm Metastasis Lung Neoplasms Neoplastic Processes Neoplasms Pathologic Processes |
Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Lung Diseases Respiratory Tract Diseases |

